West Bengal's Health Department has begun a massive drug administration campaign across 10 districts, targeting 59 blocks and urban bodies. The goal is to achieve 85% coverage and eliminate filariasis by 2030, aligning with WHO's global target.

Key Takeaways

  • Mass drug administration in 10 districts covering 59 blocks
  • Goal of 85% population coverage to eradicate filariasis by 2030
  • Free DEC and Albendazole tablets, excluding children under 2, pregnant women and critically ill

The West Bengal Health Department has launched a Mass Drug Administration (MDA) drive against lymphatic filariasis, distributing free anti‑filarial tablets in 59 identified blocks and municipalities across ten districts. The initiative, aligned with the World Health Organization’s 2030 elimination target, seeks to halt transmission and cure sub‑clinical infections.

Why Filariasis Is Hard to Detect

Filariasis, often called elephantiasis or hathipaon, remains asymptomatic for six to eight years after infection, making mass‑level detection virtually impossible. Infected individuals can still transmit the parasite through mosquito bites, creating a silent reservoir that fuels endemicity. India bears roughly 40% of the global burden, with about 217.2 million people at risk across 348 districts.

Operational Details of the Campaign

Two WHO‑approved medicines—Diethylcarbamazine (DEC) and Albendazole—are being administered free of cost. The program follows Directly Observed Therapy (DOT), where health workers watch eligible residents swallow the tablets, ensuring compliance and allowing immediate monitoring of side‑effects such as transient dizziness. Exclusions include children under two years, pregnant women, and critically ill patients.

Political Commitment and Community Trust‑Building

Health Minister Dr. Sharadwat Mukhopadhyay emphasized that the central policy now translates into a state‑level mission, urging ASHA workers and officials to cooperate. During the launch, senior officials—including the Minister of State for Health and Family Welfare, the Principal Secretary (Health), and the Director of Health Services—took the tablets themselves, a symbolic gesture to allay public fear and stigma.

Implications and Future Outlook

Achieving the 85% coverage threshold is crucial; it will not only stop new infections but also treat existing worm infestations in children, reducing long‑term complications like lymphoedema and hydrocele. Successful execution could serve as a replicable model for other high‑prevalence states, accelerating India’s progress toward the global elimination deadline.